PDL BioPharma Inc (NASDAQ:PDLI)

2.48
Delayed Data
As of Feb 23
 -0.02 / -0.80%
Today’s Change
1.96
Today|||52-Week Range
3.55
-9.49%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for PDL BioPharma Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +41.13% increase from the last price of 2.48.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in PDL BioPharma Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.11
Sales
$59.9M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -25.00%
 
 
 
 
 
 
Growthannually 55.13%
 
 
 
 
 
 

Sales

Growthquarterly -4.49%
 
 
 
 
 
 
Growthannually 21.26%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.